A Conversion Study to Determine the Relative Bioavailability of TPM MR vs TPM IR in Subjects With Epilepsy.

Trial Profile

A Conversion Study to Determine the Relative Bioavailability of TPM MR vs TPM IR in Subjects With Epilepsy.

Completed
Phase of Trial: Phase I

Latest Information Update: 24 May 2017

At a glance

  • Drugs Topiramate (Primary)
  • Indications Epilepsy
  • Focus Pharmacokinetics; Registrational
  • Sponsors Supernus Pharmaceuticals
  • Most Recent Events

    • 06 Jun 2011 Actual end date (Jan 2011) added as reported by ClinicalTrials.gov.
    • 06 Jun 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 09 Jan 2011 Additional lead trial investigator (Jennifer Stocks) identified as reported by Clinical Trials Registry - India record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top